Aim Bulletin
Vianet returns to profits, reinstates dividend
Hospitality, vending and remote asset management data specialist Vianet Group reported a strong half-year financial and operational performance on Tuesday, as it returned to profitability, reinstated its interim dividend, and reaffirmed its confidence in achieving full-year growth targets.
OptiBiotix to launch new range with India partner
OptiBiotix Health announced the upcoming launch of ‘SlimBiome’-containing products in India under Dr Morepen's new ‘LightLife’ brand on Tuesday.
Lexington Gold reports progress on Ventersburg Project
Lexington Gold reported progress at its Ventersburg Gold Project in South Africa's Free State Province on Tuesday, located in the Witwatersrand Basin - a region responsible for around 40% of the world’s gold production to date.
Cadence Minerals shares jump on latest Amapa update
Cadence Minerals announced a significant update to the pre-feasibility study for the Amapá Iron Ore Project in northern Brazil on Tuesday, increasing the project’s post-tax net present value (NPV) by 73% to $1. 97bn.
Hutchmed endometrial cancer treatment gets conditional approval in China
Hutchmed China and its partner Innovent Biologics announced conditional approval from China’s National Medical Products Administration (NMPA) for the combination of ‘Elunate’, or fruquintinib, and ‘Tyvyt’, or sintilimab injection, to treat advanced endometrial cancer with mismatch repair proficient (pMMR) tumours.
Greatland Gold executes AUD 100m syndicated facility agreement
Greatland Gold announced the execution of an AUD 100m (£51. 22m) syndicated facility agreement with ANZ, HSBC, and ING on Tuesday, enhancing its financial flexibility following the recent acquisition of the Telfer gold-copper mine and related assets from Newmont Corporation.